Medical, Pharmaceuticals, Biotech & Healthcare · Corporate Naming Intelligence

Hong Kong Pharmaceutical & Medicine Corporate Directory

Statutory Licensed Sector 100 Registered Entities
86HC Statutory Naming & Admittance Essence
Wholesale distribution and manufacture of pharmaceutical products requires licensing from the Pharmacy and Poisons Board.
Statutory Basis & Admittance
Legal Reference: Cap. 138 Pharmacy and Poisons Ordinance (Dealer & Manufacturer Licensing)
Regulatory Tier: Statutory Licence Required
Due Diligence & Verification Focus
Verify DH Licensed Wholesale Poisons Dealer license and PIC/S GMP manufacturing compliance.
Statutory Regulatory Authority

Regulated business activities under this title align with official regulatory registers.

View Official Licensed Register (DH-DRUG)
Status: All Live Dissolved
Showing 61 - 80 of 100
Corporate NameCR NumberDate of Inc.StatusAction
百奧泰生物製藥股份有限公司
Bio-Thera Solutions, Ltd.
F0028388 2020-08-28 LiveView Dossier
賽生藥業控股有限公司
SciClone Pharmaceuticals (Holdings) Limited
F0028160 2020-07-22 LiveView Dossier
華潤醫藥零售集團有限公司
China Resources Pharmaceutical Retail Group Limited
F0027592 2020-04-09 LiveView Dossier
現代中藥集團有限公司
Modern Chinese Medicine Group Co., Ltd.
F0027254 2020-01-14 LiveView Dossier
深圳市海普瑞藥業集團股份有限公司
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
F0027129 2019-12-30 LiveView Dossier
諾誠健華醫藥有限公司
InnoCare Pharma Limited
F0026766 2019-10-15 LiveView Dossier
英矽智能
InSilico Medicine Cayman TopCo
F0031532 2023-07-10 LiveView Dossier
卡萊思製藥有限公司
KAILAS PHARMA LIMITED
F0031131 2023-01-18 LiveView Dossier
武漢友芝友生物製藥股份有限公司
Wuhan YZY Biopharma Co., Ltd.
F0031006 2022-12-09 LiveView Dossier
德生堂醫藥股份有限公司
Deshengtang Pharmaceutical Co., Ltd.
F0030943 2022-11-15 LiveView Dossier
瑞麗醫美國際控股有限公司
Raily Aesthetic Medicine International Holdings Limited
F0025990 2019-06-25 LiveView Dossier
黃海醫藥集團有限公司
Huanghai Pharmaceutical Group Limited
F0026017 2019-06-26 LiveView Dossier
永泰生物製藥有限公司
Immunotech Biopharm Ltd
F0025545 2019-05-03 LiveView Dossier
康蒂尼藥業有限公司
Continent Pharmaceuticals Inc.
F0025420 2019-04-11 LiveView Dossier
聯合生物製藥(控股)有限公司
United Biopharma (Holdings) Co., Ltd.
F0025349 2019-03-20 LiveView Dossier
基石藥業
CStone Pharmaceuticals
F0025083 2018-12-13 LiveView Dossier
成都迪康藥業股份有限公司
CHENGDU DIKANG PHARMACEUTICAL CO., LTD.
F0024944 2018-11-05 LiveView Dossier
翰森製藥集團有限公司
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
F0024806 2018-09-12 LiveView Dossier
前沿生物藥業(南京)股份有限公司
FRONTIER BIOTECHNOLOGIES (NANJING) INC.
F0024775 2018-08-31 LiveView Dossier
邁博藥業有限公司
MABPHARM LIMITED
F0024702 2018-08-13 LiveView Dossier
1 2 3 4 5

Frequently Asked Questions on Hong Kong "Pharmaceutical & Medicine" Entities

Q1: What are the statutory requirements for incorporating a "Pharmaceutical & Medicine" entity in Hong Kong?
A: Wholesale distribution and manufacture of pharmaceutical products requires licensing from the Pharmacy and Poisons Board.
Q2: How to conduct anti-fraud due diligence on "Pharmaceutical & Medicine" entities before business cooperation?
A: Verify DH Licensed Wholesale Poisons Dealer license and PIC/S GMP manufacturing compliance. In addition, it is strongly advised to inspect the latest Annual Return and Certified True Copy (CTC) of the Business Registration Certificate.
Q3: If a "Pharmaceutical & Medicine" entity shows status "Dissolved", does it still hold due diligence value?
A: It retains significant legal verification and historical credit tracing value. For dissolved entities with historical litigation, debt disputes, or trademark squatting, historical directors registers, Articles of Association, and official winding-up dossiers remain accessible via 86hc.